Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor
Lahore General Hospital
Lahore General Hospital
Novartis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Stanford University
Bristol-Myers Squibb
Wroclaw Medical University
Queen's University
Endocyte
H. Lee Moffitt Cancer Center and Research Institute
University Hospitals Bristol and Weston NHS Foundation Trust
Lumos Pharma
University Hospital, Brest
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Roswell Park Cancer Institute
Mansoura University
Incyte Corporation
Mansoura University
Massachusetts General Hospital
Jonsson Comprehensive Cancer Center
Emory University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
Mansoura University
Celgene
Children's Oncology Group
Fred Hutchinson Cancer Center
Aarhus University Hospital
Mayo Clinic
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Idera Pharmaceuticals, Inc.
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Ankara Training and Research Hospital
Fred Hutchinson Cancer Center
University of Lausanne Hospitals
University of Louisville
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Ontario Clinical Oncology Group (OCOG)
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
Cellectar Biosciences, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
National Cancer Institute (NCI)